Tripartite Therapeutics Inc. (TPEX:7920)
12.65
-0.05 (-0.39%)
At close: Jul 8, 2026
Tripartite Therapeutics Market Cap
Tripartite Therapeutics has a market cap or net worth of 7.31 billion as of July 9, 2026.
Market Cap
7.31B
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
12.65
Market Cap Chart
Since May 20, 2026, Tripartite Therapeutics's market cap has increased from 4.21B to 7.31B, an increase of 73.73%. That is a compound annual growth rate of 5,537.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 9, 2026 | 7.31B | -2.77% |
| Jul 8, 2026 | 7.51B | -0.39% |
| Jul 7, 2026 | 7.54B | -6.27% |
| Jul 6, 2026 | 8.05B | -1.45% |
| Jul 3, 2026 | 8.17B | -0.36% |
| Jul 2, 2026 | 8.20B | -4.83% |
| Jul 1, 2026 | 8.61B | 3.20% |
| Jun 30, 2026 | 8.35B | 3.69% |
| Jun 29, 2026 | 8.05B | 1.50% |
| Jun 26, 2026 | 7.93B | -3.61% |
| Jun 25, 2026 | 8.23B | -0.72% |
| Jun 24, 2026 | 8.29B | -1.06% |
| Jun 23, 2026 | 8.38B | -1.40% |
| Jun 22, 2026 | 8.49B | 4.76% |
| Jun 18, 2026 | 8.11B | 10.53% |
| Jun 17, 2026 | 7.34B | 0.41% |
| Jun 16, 2026 | 7.31B | -10.55% |
| Jun 15, 2026 | 8.17B | -5.82% |
| Jun 12, 2026 | 8.67B | 5.42% |
| Jun 11, 2026 | 8.23B | -5.14% |
| Jun 10, 2026 | 8.67B | -7.59% |
| Jun 9, 2026 | 9.39B | 2.60% |
| Jun 8, 2026 | 9.15B | -15.38% |
| Jun 5, 2026 | 10.81B | 8.66% |
| Jun 4, 2026 | 9.95B | 32.94% |
| Jun 3, 2026 | 7.48B | 30.84% |
| Jun 2, 2026 | 5.72B | 11.85% |
| Jun 1, 2026 | 5.11B | 3.73% |
| May 29, 2026 | 4.93B | 3.49% |
| May 28, 2026 | 4.76B | -1.60% |
| May 27, 2026 | 4.84B | -2.40% |
| May 26, 2026 | 4.96B | 19.63% |
| May 25, 2026 | 4.15B | 13.68% |
| May 22, 2026 | 3.65B | 1.82% |
| May 21, 2026 | 3.58B | -14.83% |
| May 20, 2026 | 4.21B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| TLC BioSciences | 35.13B |
| HanchorBio | 22.30B |
| Elixiron Immunotherapeutics (Cayman) Limited | 9.95B |
| Uwell Biopharma | 7.23B |
| Intelligene | 6.44B |
| Obigen Pharma | 3.86B |
| Pet Pharm Biotech | 3.08B |
| BIONET Therapeutics | 2.40B |